Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Taiho Decitabine and Cedazuridine Research Grant Opportunity: Submit by Tuesday, January 19, 2021
Study Proposal Submission-NCCN iEnvision
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

NCCN Pfizer Biosimilars RFP Opportunity – Submit LOI by Wednesday, September 9, 2020

National Comprehensive Cancer Network® (NCCN®) is pleased to announce that it is collaborating with Pfizer Global Medical Grants (Pfizer) to offer a new grant opportunity in support of biosimilars in oncology.  The intent of this RFP is to encourage organizations in the United States to submit initial Letters of Intent (LOI) describing concepts that develop and validate enduring approaches to improve the safe, effective and efficient adoption of biosimilars in oncology. LOIs that directly measure increases in biosimilar use or improve safety, value and efficiency in both academic and/or community-based oncology practices will be prioritized. The sustainability and broad applicability of the approach, and its potential to add value to cancer care delivery, will be key factors in evaluating fundable projects.

NCCN views this collaboration with Pfizer as clear recognition of the advantages offered to the oncology community through the NCCN Oncology Research Program.  We hope you and your colleagues will be interested in this opportunity.

To be considered for funding, LOIs must be submitted by 11:59 pm ET on Wednesday, September 9, 2020.  Please direct questions regarding this RFP to Nicole Kamienski at kamienski@nccn.org with the subject line, “2020 Biosimilars Project.”

View RFP for the NCCN Pfizer Biosimilars Research Grant Opportunity

Pfizer, Inc. Grant Application System